Update Status epilepticus

Einleitung

Der Status epilepticus ist ein ernster medizinischer Notfall, der frühzeitig diagnostiziert und behandelt werden muss. Die Komplikationsrate und Mortalität insbesondere des Status epilepticus generalisierter tonisch-klonischer Anfälle (SGTKA) sind hoch. Darüber hinaus gibt es zahlreiche andere nonkonvulsive und damit weniger offensichtliche Formen des Status epilepticus, die ebenfalls rasch einer Behandlung zugeführt werden müssen, aber mitunter schwierig zu diagnostizieren sind. Immer wieder manifestieren sich akute Erkrankungen des Gehirns als Status epilepticus, die ihrerseits dringend einer Behandlung bedürfen.

Diese Arbeit ist ein Überblick über die gegenwärtigen Diagnose- und Therapieleitlinien des Status epilepticus.

• Literatur

• 1 Blume WT, Luders HO, Mizrahi E, Tassinari C et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42: 1212-1218
• 2 Working Group on Status Epilepticus. Treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of Americaʼs Working Group on Status Epilepticus. JAMA 1993; 270: 854-859
• 3 Lowenstein DH, Bleck T, Macdonald RL. Itʼs time to revise the definition of status epilepticus. Epilepsia 1999; 40: 120-122
• 4 Knake S, Rosenow F, Vescovi M et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001; 42: 714-718
• 5 Waterhouse EJ, DeLorenzo RJ. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging 2001; 18: 133-142
• 6 deLorenzo RJ, Pellock JM, Towne AR et al. Epidemiology of status epilepticus. J Clin Neurophysiol 1995; 12: 316-325
• 7 Rona S, Rosenow F, Arnold S et al. A semiological classification of status epilepticus. Epileptic Disord 2005; 7: 5-12
• 8 Heckmann JG, Lang CJ, Stefan H et al. The vegetarian who ate a sausage with curry sauce. Lancet Neurol 2003; 2: 62
• 9 Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990; 5: 49-60
• 10 Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007; 6: 329-339
• 11 Mayer SA, Claassen J, Lokin J et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59: 205-210
• 12 Legriel S, Bruneel F, Sediri H et al. Early EEG monitoring for detecting postanoxic status epilepticus during therapeutic hypothermia: a pilot study. Neurocrit Care 2009; 11: 338-344
• 13 Sutter R, Fuhr P, Grize L et al. Continuous video-EEG monitoring increases detection rate of nonconvulsive status epilepticus in the ICU. Epilepsia 2011; 52: 453-457
• 14 Kuchta J, Klug N, Ernestus RI. Nonconvulsive status epilepticus as a possible cause of coma in neurosurgical intensive care. Cen Eur Neurosurg 2009; 70: 176-179
• 15 Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993; 43: 483-488
• 16 Alldredge BK, Gelb AM, Isaacs SM et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345: 631-637
• 17 Prasad K, Al-Roomi K, Krishnan PR et al. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2005; CD003723
• 18 Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav 2004; 5: 253-255
• 19 Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev 2008; CD001905
• 20 Ashrafi MR, Khosroshahi N, Karimi P et al. Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. Eur J Paediatr Neurol 2010; 14: 434-438
• 21 de Haan GJ, van der GP, Doelman G et al. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia 2010; 51: 478-482
• 22 McMullan J, Sasson C, Pancioli A et al. Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med 2010; 17: 575-582
• 23 Arya R, Gulati S, Kabra M et al. Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. Epilepsia 2011; 52: 788-793
• 24 Claassen J, Hirsch LJ, Emerson RG et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002; 43: 146-153
• 25 Rossetti AO, Milligan TA, Vulliemoz S et al. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011; 14: 4-10
• 26 Vasile B, Rasulo F, Candiani A et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003; 29: 1417-1425
• 27 Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011; 134: 2802-2818
• 28 Holtkamp M, Othman J, Buchheim K et al. A “malignant” variant of status epilepticus. Arch Neurol 2005; 62: 1428-1431
• 29 Holtkamp M, Othman J, Buchheim K et al. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005; 76: 534-539
• 30 Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia 1999; 40 (Suppl. 01) S3-8
• 31 Drislane FW, Blum AS, Lopez MR et al. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009; 50: 1566-1571
• 32 Cooper AD, Britton JW, Rabinstein AA. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol 2009; 66: 1505-1509